Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
NCT ID: NCT04681339
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2022-09-16
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Improvement and Deterioration of Community Acquired Pneumonia in Children
NCT06720441
PICNIC Study - PatIent Centered aNtIbiotic Courses in Children With Medical Complexity
NCT06364514
Respiratory Tract Infections and Prescription Drugs in Children and in Pregnancy
NCT01109589
The Norwegian Antibiotics for Pneumonia in Children Study
NCT03446534
Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years
NCT00843895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pneumonia with antibiotics
Children with non-severe community acquired pneumonia and fever: managed with antibiotics
Antibiotic treatment
Antibiotic treatment
Pneumonia without antibiotics
Children with non-severe community acquired pneumonia and fever: managed without antibiotics
No antibiotic treatment
No antibiotic treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antibiotic treatment
Antibiotic treatment
No antibiotic treatment
No antibiotic treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission diagnosis pneumonia or pneumonia diagnosis within 48 hours of admission
* Written informed consent by care giver
Exclusion Criteria
3 Months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gemeinschaftskrankenhaus Herdecke, Germany
UNKNOWN
ARCIM Institute Academic Research in Complementary and Integrative Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Vagedes, Dr
Role: PRINCIPAL_INVESTIGATOR
Arcim Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Die Filderklinik
Filderstadt, Baden-Wurttemberg, Germany
Herdecke Community Hospital
Herdecke, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PKA-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.